NCT06107062View on ClinicalTrials.gov

Longitudinal Outpatient Treatment for Cannabis Use Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2029

Conditions
Cannabis Use Disorder
Interventions
DRUG

Cannabidiol - fsCBD

Full-spectrum (i.e., fsCBD, 7.8mg THC (3.4mg BID)), plant-derived CBD capsules produced by Ecofibre/Ananda Hemp will be used.

DRUG

Placebo

Placebo arm

DRUG

Cannabidiol - bsCBD

Broad-spectrum (i.e., bsCBD, 0% THC), plant-derived CBD capsules produced by Ecofibre/Ananda Hemp will be used

Trial Locations (1)

80301

RECRUITING

University of Colorado Boulder, Boulder

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Colorado, Boulder

OTHER